メインコンテンツに移動

Development Pipeline

EA Pharma Co., Ltd. Development Pipeline

as of September, 2023

Therapeutic
Area
Development Code
(Generic name)
Development Stage Indication Note
Gastrointestinal
diseases
Gastrointestinal
diseases
AJG555 Phase Ⅲ Chronic constipation in children under 2 years of age (Additional Dosage and Administration) Oral
Gastrointestinal
diseases
AJM347 Phase I Inflammatory bowel disease Oral
Gastrointestinal
diseases
EA1080 Phase I Inflammatory bowel disease Oral
Gastrointestinal
diseases
EA3571 Phase I Nonalcoholic steatohepatitis Oral
Neurology Neurology EA4017 Phase I Chemotherapy-
induced peripheral neuropathy
Oral